Terrestristat Liquid
NDC Package 44911-0677-1
Package Information
Terrestristat (alfalfa, avena sativa, fucus vesiculosus, aralia quinquefolia, natrum carbonicum, thyroidinum (suis), cerebrum suis, pineal gland (suis), rhododendron chrysanthum, agate, argentum nitricum, cadmium iodatum, calcarea phosphorica, coffea cruda, cuprum metallicum, mercurius corrosivus, phosphoricum acidum, phosphorus, quartz, silicea, strontium carbonicum, radium bromatum, carcinosin, tarentula cubensis, x-ray, holmium metallicum, uranium nitricum.) liquids is adults and children 5 to 10 drops orally, 3 times daily or as otherwise directed by a health care professional. This formulation utilizes a liquid delivery system. Marketed by Energique, Inc., this product is identified by NDC 44911-0677.
Identification & Billing
Clinical Specifications
- MEDICAGO SATIVA WHOLE 30 [hp_X]/mL
- AVENA SATIVA FLOWERING TOP 6 [hp_X]/mL
- FUCUS VESICULOSUS 12 [hp_X]/mL
- AMERICAN GINSENG 3 [hp_X]/mL
- SODIUM CARBONATE 12 [hp_X]/mL
- THYROID 30 [hp_X]/mL
- SUS SCROFA CEREBRUM 12 [hp_X]/mL
- SUS SCROFA PINEAL GLAND 3 [hp_X]/mL
- RHODODENDRON AUREUM LEAF 12 [hp_C]/mL
- SILICON DIOXIDE 30 [hp_X]/mL
- SILVER NITRATE 3 [hp_X]/mL
- CADMIUM IODIDE 12 [hp_X]/mL
- TRIBASIC CALCIUM PHOSPHATE 12 [hp_X]/mL
- ARABICA COFFEE BEAN 12 [hp_X]/mL
- COPPER 16 [hp_X]/mL
- MERCURIC CHLORIDE 10 [hp_X]/mL
- PHOSPHORIC ACID 12 [hp_X]/mL
- PHOSPHORUS 12 [hp_X]/mL
- STRONTIUM CARBONATE 6 [hp_X]/mL
- RADIUM BROMIDE 12 [hp_X]/mL
- HUMAN BREAST TUMOR CELL 8 [hp_X]/mL
- CITHARACANTHUS SPINICRUS 8 [hp_X]/mL
- ALCOHOL, X-RAY EXPOSED (1000 RAD) 6 [hp_X]/mL
- HOLMIUM 12 [hp_X]/mL
- URANYL NITRATE HEXAHYDRATE 15 [hp_C]/mL
- Allergens - [CS]
- Blood Coagulation Factor - [EPC] (Established Pharmacologic Class)
- Calcium - [CS]
- Cations, Divalent - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Copper - [CS]
- Copper-containing Intrauterine Device - [EPC] (Established Pharmacologic Class)
- Decreased Embryonic Implantation - [PE] (Physiologic Effect)
- Decreased Sperm Motility - [PE] (Physiologic Effect)
- Dietary Proteins - [CS]
- Increased Coagulation Factor Activity - [PE] (Physiologic Effect)
- Increased Histamine Release - [PE] (Physiologic Effect)
- Inhibit Ovum Fertilization - [PE] (Physiologic Effect)
- Non-Standardized Food Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Phosphate Binder - [EPC] (Established Pharmacologic Class)
- Phosphate Chelating Activity - [MoA] (Mechanism of Action)
- Plant Proteins - [CS]
- Seed Storage Proteins - [CS]
Regulatory & Marketing
Hierarchy Structure
- 44911 - Energique, Inc.
- 44911-0677 - Terrestristat
- 44911-0677-1 - 30 mL in 1 BOTTLE, DROPPER
- 44911-0677 - Terrestristat
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 44911-0677-1 identifies a specific commercial package of 30 ml in 1 bottle, dropper of Terrestristat, a human over the counter drug labeled by Energique, Inc.. This liquid is formulated for oral use and contains medicago sativa whole; avena sativa flowering top; fucus vesiculosus; american ginseng; sodium carbonate; thyroid; sus scrofa cerebrum; sus scrofa pineal gland; rhododendron aureum leaf; silicon dioxide; silver nitrate; cadmium iodide; tribasic calcium phosphate; arabica coffee bean; copper; mercuric chloride; phosphoric acid; phosphorus; strontium carbonate; radium bromide; human breast tumor cell; citharacanthus spinicrus; alcohol, x-ray exposed (1000 rad); holmium; uranyl nitrate hexahydrate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Energique, Inc. on November 17, 2023. The current certification is valid through December 31, 2026.
How is this Energique, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 44911067701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.